Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Message Automation

Message Automation?uq=oeHSfu7P
2003 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of post-trade OTC derivatives platform designed to manage the challenges of the new landscape OTC world. The company's post-trade OTC derivatives platform supports all asset classes, have ready-made connectivity in the OTC market and respond quickly to changes by providing house and client clearing, affirmation and confirmation, management of incoming data from CCP's and brokers, trade & transaction reporting, SEF connectivity and collateral management, enabling tier-1 and tier-2 banks and buy-side institutions to achieve a truly integrated strategic approach to OTC derivative control.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Other IT Services
Other Industries
Business/Productivity Software
Primary Office
  • Warnford Court
  • 29 Throgmorton Street
  • London EC2N 2AT
  • England

+44 020 0000 0000

Message Automation Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Message Automation‘s full profile, request access.

Request full access to PitchBook

Message Automation Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Message Automation‘s full profile, request access.

Request full access to PitchBook

Message Automation Executive Team (3)

Name Title Board
Seat
Contact
Info
Hugh Daly Co-Founder & Chief Executive Officer
David Farmery Chief Operating Officer
Neil Thomas Co-Founder & Chief Technology Officer